Additionally, spontaneous interconversion between HER2-positive and negative expression in CTC and its potential prognostic and clinical implications has been reported [11], supporting the need for a reassessment of HER2 expression during the course of the breast cancer disease. Here, ERBB2 is linked to breast cancer.